Stay updated on Long-term Baricitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Long-term Baricitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Long-term Baricitinib in Atopic Dermatitis Clinical Trial page
- Check5 days agoChange DetectedA banner announces an NIH website transition and says that some content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check12 days agoChange DetectedThe footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.3%

- Check19 days agoChange DetectedThe site footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.3%

- Check39 days agoChange DetectedThe page now displays a 403 Forbidden message, indicating restricted access, and the previously listed study content and documents are removed, altering how the study information is presented.SummaryDifference20%

- Check60 days agoChange DetectedA new site revision is now listed as v3.6.6, and the previous revision v3.6.5 was removed. This indicates a software version update reflected on the page.SummaryDifference0.0%

- Check67 days agoChange DetectedAn NIH grant/contract attribution line was added to the study record, indicating funding support for the trial.SummaryDifference0.0%

Stay in the know with updates to Long-term Baricitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Baricitinib in Atopic Dermatitis Clinical Trial page.